156 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
STT State Street Corporation $85.88 $32.55B N/A
Article Searches
The Latest Shot in the ETF Price Wars https://www.fool.com/investing/etf/2017/10/20/the-latest-shot-in-the-etf-price-wars.aspx?source=iedfolrf0000001 Oct 20, 2017 - Costs are approaching zero, and that's good news for smart investors.
5 Major Bank Stocks Poised to Beat Earnings Estimates in Q3 http://www.zacks.com/stock/news/278461/5-major-bank-stocks-poised-to-beat-earnings-estimates-in-q3?cid=CS-ZC-FT-278461 Oct 11, 2017 - There are a few major banks that are expected to outshine their peers.
SEC Urged by AFL-CIO to Review Aug 31 Trade of Navient Stock http://www.zacks.com/stock/news/278418/sec-urged-by-afl-cio-to-review-aug-31-trade-of-navient-stock?cid=CS-ZC-FT-278418 Oct 11, 2017 - Labor union federation, AFL-CIO, has urged the SEC to investigate into the three large block trades of Navient (NAVI) stock conducted on Aug 31, 2017.
Can JPMorgan's (JPM) Q3 Earnings Hide Trading Weakness? http://www.zacks.com/stock/news/278068/can-jpmorgans-jpm-q3-earnings-hide-trading-weakness?cid=CS-ZC-FT-278068 Oct 09, 2017 - The likely damage to JPMorgan Chase & Co.'s (JPM) Q3 results by a slump in trading revenue might be offset by improvement in other segments -- primarily investment banking.
BB&T Poised for Revenue Growth, Rising Costs Raise Concern http://www.zacks.com/stock/news/276903/bbt-poised-for-revenue-growth-rising-costs-raise-concern?cid=CS-ZC-FT-276903 Sep 25, 2017 - Though increase in loans and deposits will aid in top-line growth, an elevated expense level remains a major near-term concern for BB&T Corporation (BBT).
Why This is the Best Time to Buy State Street (STT) Stock http://www.zacks.com/stock/news/276420/why-this-is-the-best-time-to-buy-state-street-stt-stock?cid=CS-ZC-FT-276420 Sep 20, 2017 - Easing margin pressure and solid capital position should support State Street's (STT) financials. However, elevated expenses remain a concern.
State Street's (STT) Management Presents at Barclays Global Financial Services Conference (Transcript) https://seekingalpha.com/article/4106241-state-streets-stt-management-presents-barclays-global-financial-services-conference?source=feed_all_articles Sep 12, 2017 - State Street Corporation (NYSE:STT) Barclays Global Financial Services Conference September 12, 2017, 10:30 AM ET Executives Eric Aboaf - CFO Analysts Jason Goldberg - Barclays Capital Presentation Ja
6 Reasons That Make Old Second Bancorp an Attractive Pick http://www.zacks.com/stock/news/274550/6-reasons-that-make-old-second-bancorp-an-attractive-pick?cid=CS-ZC-FT-274550 Sep 05, 2017 - Old Second Bancorp's (OSBC) revenue growth and expense control measures, along with a reasonable valuation and strong capital position, reflect its upside potential.
Big Investors Are Buying Cara Therapeutics Stock. Should You? https://www.fool.com/investing/2017/08/31/big-investors-are-buying-cara-therapeutics-stock-s.aspx?source=iedfolrf0000001 Aug 31, 2017 - Institutional ownership of Cara Therapeutics is growing. Is the biotech stock a smart pick for smaller investors?
Regions Financial on Track to Achieve Cost Control Targets http://www.zacks.com/stock/news/273361/regions-financial-on-track-to-achieve-cost-control-targets?cid=CS-ZC-FT-273361 Aug 25, 2017 - Regions Financial's (RF) expense control measures along with robust capital position reflect its upside potential. However, legal costs remain a woe.

Pages: 1...8910111213141516

<<<Page 13>